JULIA
ORIGÜEN SABATER
Profesora asociada de Ciencias de la Salud
FRANCISCO
LÓPEZ MEDRANO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con FRANCISCO LÓPEZ MEDRANO (23)
2024
-
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324
2022
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Early Treatment with Sotrovimab for Covid-19
The New England journal of medicine
2021
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2020
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
2019
-
Toxin B PCR amplification cycle threshold adds little to clinical variables for predicting outcomes in clostridium difficile infection: A retrospective cohort study
Journal of Clinical Microbiology, Vol. 57, Núm. 2
2018
-
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test
Clinical Microbiology and Infection, Vol. 24, Núm. 4, pp. 414-421
-
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study
Transplant International, Vol. 31, Núm. 2, pp. 187-197
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus
Infectious Diseases, Vol. 50, Núm. 11-12, pp. 837-846
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
Atherosclerosis, Vol. 269, pp. 204-210
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19
2017
-
Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation
Transplant Infectious Disease, Vol. 19, Núm. 2
2016
-
Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options
Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 575-584
-
Reply to “Old Habits Die Hard: Screening for and Treating Asymptomatic Bacteriuria After Kidney Transplantation”
American Journal of Transplantation
-
Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial
American Journal of Transplantation, Vol. 16, Núm. 10, pp. 2943-2953
2015
-
Executive summary. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 10, pp. 680-687
-
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18